Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $1.48 Million |
|---|---|
| Enterprise Value | $-3,431,789.00 |
| Earnings per Share | $-98 |
| Beta | -0.61 |
| Outstanding Shares | 1,304,000 |
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.66 |
| Price to Sales | - |
| Price to Book Ratio | -0.13 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.08 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.05 |
| Debt to Equity | -0.01 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 5.69%▲ 0.93% |
|---|---|
| Total Invested | $504,670▼ 57.23% |
| Investors Holding | 23▲ 1.00% |
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company ...